Not applicableStudy completedNCT05637632What this trial is testingAssessment of Recombinant HAT-RDT SpecificityWho this might be right forHuman African Trypanosomiasis Institute of Tropical Medicine, Belgium 1,504
Large-scale testing (Phase 3)Study completedNCT03974178What this trial is testingFexinidazole in Human African Trypanosomiasis Due to T. b. RhodesienseWho this might be right forTrypanosomiasis, AfricanSleeping SicknessTrypanosoma Brucei Rhodesiense; Infection Drugs for Neglected Diseases 45
Post-approval studies (Phase 4)Study completedNCT00906880What this trial is testingClinical Study to Assess the Tolerability, Feasibility and Effectiveness of Nifurtimox and Eflornithine (NECT) for the Treatment of Trypanosoma Brucei Gambiense Human African Trypanosomiasis (HAT) in the Meningo-encephalitic PhaseWho this might be right forHuman African Trypanosomiasis Drugs for Neglected Diseases 630
Large-scale testing (Phase 3)Study completedNCT01685827What this trial is testingPivotal Study of Fexinidazole for Human African Trypanosomiasis in Stage 2Who this might be right forHuman African Trypanosomiasis (HAT)Sleeping Sickness Drugs for Neglected Diseases 394
Not applicableStudy completedNCT06060600What this trial is testingA Retrospective Analysis of Suramin Treatment for Stage 1 TBRWho this might be right forTrypanosoma Brucei Rhodesiense; Infection Paxmedica 345
Large-scale testing (Phase 3)Study completedNCT03025789What this trial is testingFexinidazole in Human African Trypanosomiasis Due to T.b. Gambiense at Any StageWho this might be right forTrypanosomiasis, AfricanSleeping SicknessTrypanosomiasis; Gambian Drugs for Neglected Diseases 174
Large-scale testing (Phase 3)Study completedNCT02184689What this trial is testingEfficacy and Safety of Fexinidazole in Children at Least 6 Years Old and Weighing Over 20 kg With Human African Trypanosomiasis (HAT) Due to T.b. Gambiense: a Prospective, Multicentre, Open Study, plug-in to the Pivotal StudyWho this might be right forHuman African Trypanosomiasis (HAT) Drugs for Neglected Diseases 125
Large-scale testing (Phase 3)Study completedNCT03087955What this trial is testingEfficacy and Safety of Acoziborole (SCYX-7158) in Patients With Human African Trypanosomiasis Due to T.b. GambienseWho this might be right forTrypanosomiasis, AfricanGambiense TrypanosomiasisSleeping Sickness Drugs for Neglected Diseases 208
Large-scale testing (Phase 3)Ended earlyNCT00489658What this trial is testingEflornithine + Nifurtimox Late-Stage Human African Trypanosomiasis (HAT)in West Nile, UgandaWho this might be right forTrypanosomiasis, African Epicentre 31
Not applicableWithdrawnNCT05645822What this trial is testingScreen and Treat Implementation for HAT ControlWho this might be right forSleeping SicknessTrypanosomiasis, African Institute of Tropical Medicine, Belgium
Large-scale testing (Phase 3)Study completedNCT02169557What this trial is testingEfficacy and Safety of Fexinidazole in Patients With Stage 1 or Early Stage 2 Human African Trypanosomiasis (HAT) Due to T.b. Gambiense: a Prospective, Multicentre, Open-label Cohort Study, plug-in to the Pivotal StudyWho this might be right forHuman African Trypanosomiasis (HAT) Drugs for Neglected Diseases 230
Not applicableWithdrawnNCT03394976What this trial is testingProspective Evaluation of an RDT to Screen for Gambiense HAT and Diagnose P. Falciparum MalariaWho this might be right forHuman African Trypanosomiasis Foundation for Innovative New Diagnostics, Switzerland
Large-scale testing (Phase 3)Study completedNCT05256017What this trial is testingSafety and Tolerability Study of Acoziborole in g-HAT Seropositive SubjectsWho this might be right forTrypanosomiasis, AfricanTrypanosoma Brucei Gambiense; InfectionSleeping Sickness Drugs for Neglected Diseases 1,208